The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNahl Group Regulatory News (NAH)

Share Price Information for Nahl Group (NAH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 68.00
Bid: 66.00
Ask: 68.50
Change: 0.00 (0.00%)
Spread: 2.50 (3.788%)
Open: 68.00
High: 0.00
Low: 0.00
Prev. Close: 68.00
NAH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

COVID-19 Update

20 Apr 2020 07:00

RNS Number : 1202K
NAHL Group PLC
20 April 2020
 

 

20 April 2020

NAHL Group PLC

("NAHL" or the "Group")

 

COVID-19 Update

 

NAHL (AIM: NAH), the leading consumer marketing and services business focused on the UK legal services market, today provides an update in light of the constantly evolving COVID-19 situation.

 

Following the emergence of the COVID-19 virus in the UK in late February, the Board's focus has switched to tackling the immediate short-term challenges for the business and taking the appropriate actions to protect cash, reduce costs and ensure there is sufficient liquidity to run the business through a prolonged period of disruption. Management have modelled the financial impact of a number of potential scenarios on the business but, at this stage, given the rapidly evolving Government response, it is too early to quantify the full impact with any degree of certainty. Consequently, the Group is suspending all forward guidance until circumstances and impacts surrounding COVID-19 become clearer.

 

The Board's overriding priority has been the continued health, safety and wellbeing of our people and supporting our customers and business partners through these unprecedented times. To that end, the Group's business continuity plans were swiftly implemented, with our well supported systems enabling staff to work remotely with full support.

 

Cost savings and liquidity

 

Since mid-March, the Group's Critical Care business has remained resilient with only a modest level of impact to date. However, the Group's Personal Injury division has suffered a more significant reduction in enquiries and its Residential Property division has suffered in line with the UK property market which has come to a standstill. These challenges will impact the business in both the short and long-term.

 

In response, the Board has taken a number of measures including reducing property and lease costs, leveraging IT to support broader based home working, delaying capital expenditure and optimising the structure of the business to maximise efficiencies. Across these initiatives, management are targeting significant annualised cash savings.

 

Furthermore, the Group is making use of the Government Job Retention Scheme and has furloughed around a third of staff. Members of the Group's leadership team have voluntarily taken a temporary salary cut of between 10 and 20%; the Board has taken a 20% reduction in salaries or fees; and the Group has deferred its annual salary review. The Board is extremely grateful for the sacrifices made by its employees in the current crisis and greatly appreciates the positive attitude shown by all staff.

 

At 31 December 2019, the Group had net debt of £21 million with a £25 million Revolving Credit Facility committed until December 2021. At 31 March 2020, net debt remained at £21 million and we believe that the Group will be able to manage net debt within the current headroom.

 

Final Results and Outlook

 

On 23 March 2020, the Board announced a delay in issuing its Final Results for 2019 following guidance from the Financial Conduct Authority and AIM. Now that the reporting moratorium has been lifted, and having consulted with its advisers including the Group's auditors, the Group intends to publish its Final Results during the last week of April with an Annual General Meeting planned for early June 2020. Further details will be announced in due course.

 

Given its experience in navigating change in difficult markets, the Board remains confident in the Group's ability to emerge from this period as a sustainable business.

 

 

 

For further information please call:

 

NAHL Group plc

Russell Atkinson (CEO)

James Saralis (CFO)

 

via finnCap

Tel: +44 (0) 20 7220 0500

finnCap Ltd (NOMAD & Broker)

Julian Blunt / James Thompson (Corporate Finance)

Andrew Burdis (Corporate Broking)

Tel: +44 (0) 20 7220 0500

 

 

FTI Consulting (Financial PR)

Alex Beagley

James Styles

Sam Macpherson

 

Tel: +44 (0) 20 3727 1000

 

Notes to Editors

NAHL Group plc (AIM: NAH) is a leader in the Consumer Legal Services ("CLS") market. The Group provides services and products to individuals and businesses in the CLS market through its three divisions:

 

· Personal Injury provides outsourced marketing services to law firms through National Accident Helpline and claims processing services to individuals through Your Law, Law Together and National Accident Law.

· Critical Care provides a range of specialist services in the catastrophic and serious injury market to both claimants and defendants through Bush and Company Rehabilitation.

· Residential Property provides marketing services to law firms and conveyancers as well as surveys to individuals through Fitzalan Partners. It also provides property searches through Searches UK.

 

More information is available at www.nahlgroupplc.co.uk and www.national-accident-helpline.co.uk.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDIMMTTMTMTMRM
Date   Source Headline
24th Apr 20245:06 pmRNSIssue of Equity from Share Options and TVR
23rd Apr 20247:00 amRNSNotice of Results and Investor Presentation
5th Apr 20241:51 pmRNSHolding(s) in Company
5th Apr 202412:19 pmRNSResponse to speculation
8th Mar 20247:00 amRNSRenewal of Banking Facilities
24th Jan 20247:00 amRNSYear End Trading Update
30th Oct 20237:00 amRNSGrant of options under SAYE Scheme
19th Oct 20236:07 pmRNSHolding(s) in Company
26th Sep 20237:00 amRNSInterim Results
13th Sep 20237:00 amRNSNotice of Results and Investor Presentation
31st Jul 20235:00 pmRNSTotal Voting Rights
26th Jul 20237:00 amRNSHalf Year Trading Update
2nd Jun 20235:24 pmRNSDirector/PDMR Shareholding
31st May 20235:00 pmRNSTotal Voting Rights
31st May 20233:50 pmRNSIssue of Equity and Total voting rights
25th May 20231:50 pmRNSHolding(s) in Company
25th May 20231:19 pmRNSResult of AGM
25th May 20237:00 amRNSAGM Statement
19th May 20233:16 pmRNSIssue of Equity from Exercise of Share Options
18th May 20237:49 amRNSHolding(s) in Company
2nd May 202312:57 pmRNSGrant of Awards under Group Share Option Plan
28th Apr 20238:28 amRNSAnnual Report & Accounts and Notice of AGM
25th Apr 20237:00 amRNSSale of Homeward Legal
24th Apr 20232:43 pmRNSHolding(s) in Company
24th Mar 20234:59 pmRNSFinal Results – replacement
22nd Mar 20237:00 amRNSFinal Results
16th Mar 20237:00 amRNSNotice of Investor Presentation
24th Jan 20237:00 amRNSYear End Trading Update and Notice of Results
5th Dec 20222:42 pmRNSHolding(s) in Company
27th Sep 20227:00 amRNSInterim Results
22nd Sep 20227:00 amRNSNotice of Results and Investor Presentation
15th Sep 20227:00 amRNSDirectorate changes
2nd Aug 20221:15 pmRNSHolding(s) in Company
1st Aug 20227:00 amRNSHalf Year Trading Update
14th Jul 20221:58 pmRNSHolding(s) in Company
7th Jul 20224:44 pmRNSHoldings in Company
15th Jun 202212:13 pmRNSResult of AGM
15th Jun 20227:00 amRNSAGM Statement
10th May 20227:00 amRNSAnnual Report & Accounts and Notice of AGM
28th Apr 20227:00 amRNSGrant of Awards under Group Share Option Plan
29th Mar 20227:00 amRNSFinal Results
15th Mar 20227:00 amRNSNotice of Investor Presentation
11th Feb 20227:00 amRNSChange of Nominated Adviser and Broker
19th Jan 20227:00 amRNSTrading Update and Revised Banking Facility
5th Jan 20225:02 pmRNSHolding(s) in Company
9th Dec 20217:00 amRNSIssue of Equity from Exercise of Share Options
14th Oct 20214:41 pmRNSSecond Price Monitoring Extn
14th Oct 20214:36 pmRNSPrice Monitoring Extension
28th Sep 20217:00 amRNSInterim Results
23rd Sep 20217:00 amRNSNotice of Investor Presentation

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.